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Abstract
Introduction: Tools that allow for in silico optimization of available malaria control strategies can assist the decision-making
process for prioritizing interventions. The OpenMalaria stochastic simulation modeling platform can be applied to simulate
the impact of interventions singly and in combination as implemented in Rachuonyo South District, western Kenya, to
support this goal.
Methods: Combinations of malaria interventions were simulated using a previously-published, validated model of malaria
epidemiology and control in the study area. An economic model of the costs of case management and malaria control
interventions in Kenya was applied to simulation results and cost-effectiveness of each intervention combination compared
to the corresponding simulated outputs of a scenario without interventions. Uncertainty was evaluated by varying health
system and intervention delivery parameters.
Results: The intervention strategy with the greatest simulated health impact employed long lasting insecticide treated net
(LLIN) use by 80% of the population, 90% of households covered by indoor residual spraying (IRS) with deployment starting
in April, and intermittent screen and treat (IST) of school children using Artemether lumefantrine (AL) with 80% coverage
twice per term. However, the current malaria control strategy in the study area including LLIN use of 56% and IRS coverage
of 70% was the most cost effective at reducing disability-adjusted life years (DALYs) over a five year period.
Conclusions: All the simulated intervention combinations can be considered cost effective in the context of available
resources for health in Kenya. Increasing coverage of vector control interventions has a larger simulated impact compared
to adding IST to the current implementation strategy, suggesting that transmission in the study area is not at a level to
warrant replacing vector control to a school-based screen and treat program. These results have the potential to assist
malaria control program managers in the study area in adding new or changing implementation of current interventions.
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Introduction
Important progress has been made in the past decade in
reducing malaria morbidity and mortality in Kenya, but it is not
obvious which additional tools and strategies should be the next
priority to include in the package of malaria control interventions
in a given area to keep transmission levels low, especially given the
threat of resistance of the parasite and vectors to antimalarial
drugs and insecticides [1,2]. Application of mathematical models
for use in simulations of malaria epidemiology and control can
help estimate the impact of interventions singly and in combina-
tion to support this goal.
OpenMalaria, a stochastic simulation modeling platform [3],
has previously been applied to Rachuonyo South District, Nyanza
Province, Kenya in order to describe the epidemiology of malaria
and control area and identify uncertainty in key parameters
pertaining to the study area [4]. Results indicate that the
OpenMalaria model, as parameterized for Rachuonyo South
District, can be extended to simulate the epidemiologic and
economic impact of combinations of a range of existing and
potential future malaria control interventions, singly and in
combination, implemented in the study area [4]. This study
addresses the cost effectiveness of feasible malaria control
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interventions in Rachuonyo South District for a five year time
horizon.
Study area
Rachuonyo South District in Homa Bay County of Nyanza
Province, Kenya is a highland fringe area with altitude between
1,400 and 1,600 meters. Ethnicity is predominantly Luo and
homesteads are distributed broadly across a rolling landscape
intersected with small streams and rivers. The area is character-
ized by generally low malaria endemicity with marked seasonal
and inter-annual variations in transmission [5,6]. As a result of a
2009 survey, community level parasite prevalence was estimated to
be 4.5% and transmission was measured with an entomological
inoculation rate of 1.5 infectious bites per person per year [4], but
subsequent surveys in the study area showed community-level
parasite prevalence to be as high as 15.5% [7]. This is in the range
of the reported 2010 national average parasite prevalence of 12%,
but low compared prevalence in the neighboring lowland districts
bordering Lake Kisumu that reach 38% in children under 15 [8].
Malaria transmission peaks twice each year following rainfall
patterns with a long rainy season between March and June and a
shorter season in October and November. Recent studies indicate
that Plasmodium falciparum is transmitted not only by Anopheles
funestus and An. arabiensis, but also by another, as yet
unidentified secondary vector with outdoor-active, early-biting
behavior, potentially challenging the effectiveness of current vector
control interventions targeting indoor-biting mosquitoes [9].
The main malaria control methods are currently mass-
distribution of LLINs, annual indoor residual spraying (IRS) with
pyrethroids, and prompt and effective treatment [8,10,11].
Kenya’s health system relies heavily on user fees and other out-
of-pocket payments, with exemptions for children under five, the
poor, and special conditions and services such as malaria and
tuberculosis, in both the formal public and private sector [12]. The
latter provides a substantial proportion of primary care services
(31%) [13].
Rachuonyo South is one of a number of field sites of the
Malaria Transmission Consortium (MTC), a project with the goal
of enabling operational program managers to achieve optimal
implementation of transmission-reducing malaria control tech-
niques. Active between 2009 and 2012, MTC surveys provided
detailed entomological studies of species composition and biting
behavior [9], transmission estimation and community evaluation
of LLINs and IRS versus LLINs alone. To complement these
studies, a trial to assess the effect of hotspot-targeted interventions
in populations living both inside and outside hotspots has recently
been implemented [14]. Targeted interventions of this trial
included distribution of LLINs, IRS, larviciding and focal
screening and treatment.
Methods
Ethics approval
The study proposal received ethics approval from the Ethical
Review Committee (ERC) of the Kenya Medical Research
Institute (KEMRI) Nairobi under proposal number SSC 2163,
the London School of Hygiene & Tropical Medicine ethics
committee (#6111), and from Centers for Disease Control and
Prevention (with exempt status).
OpenMalaria modelling platform
A team at the Swiss Tropical and Public Health Institute (Swiss
TPH) and Liverpool School of Tropical Medicine (LSTM)
developed the OpenMalaria platform comprising stochastic
simulation models of transmission of malaria based on the
simulation of infection in individuals. These models are able to
evaluate the impact (cost-effectiveness, clinical, epidemiological
and entomological) of numerous intervention strategies for malaria
control [3,15–19]. The details of the methods to build and
parameterize the transmission model used in this project have
been published elsewhere [3,15–19]. Briefly, individual infections
in humans are simulated by stochastic series of parasite densities,
which determine an individual’s morbidity and mortality risks as
well as their infectiousness to vectors [3,15]. These simulated
infections are linked to a model of transmission of malaria between
humans and mosquitoes and to models of interventions [3,15,16].
Model parameterization and experiment design
The scenario describing the current intervention mix was
parameterized using a previously-published model of malaria
epidemiology and control in Rachuonyo South District, validated
with observed data from the site-specific MTC studies described
above [4]. Parameterization of this baseline scenario included the
characteristics of vector composition and biting behavior, season-
ality of transmission, treatment seeking behavior and existing
malaria control interventions in the study area as described above.
Combinations of interventions for the experiment were chosen
in collaboration with malaria control personnel in the study area
to correspond to a 2011–2012 intervention evaluation trial [14].
LLIN use the previous night was simulated at the proportion
observed in the population (56%) and an increased level (80%)
with one mass distribution at the beginning of the study period.
Proportion of houses receiving IRS with a pyrethroid was
simulated at the proportion observed in the population (70%)
and an increased level (90%). The implementation schedule for
IRS was simulated at the observed once-yearly schedule of
alternating start dates in April and then June, as well as consistent
implementation starting in April, May, and June. Intermittent
screen and treatment of school aged children with Artemether
lumefantrine (AL) was simulated at low (40%) and high (80%)
coverage, and a frequency of either once (January, May and
September) or twice (initial months plus March, July and
November) per school term. These combinations, as well as their
coverage levels and implementation schedules, are described in
Table 1.
Model Implementation
Each intervention strategy was simulated in a population of
100,000 individuals. To simulate the status quo prior to
interventions, simulations were run for one human life span to
induce an ‘‘equilibrium’’ level of immunity. Forward simulations
of each intervention combination were made using an ensemble of
14 model variants for malaria in humans to address model
uncertainty [18], with each model variant repeated with five
random seeds to address stochasticity. Each intervention combi-
nation was simulated for a period of five years assuming 28% of
fevers receive an antimalarial [8]. Simulations were run over the
malariacontrol.net volunteer computing platform (www.
malariacontrol.net).
Estimating the cost of malaria case management and
interventions
Case management costing model. Malaria case manage-
ment costs were based on a societal perspective; direct costs to the
health systems are considered, as well as direct expenditures
associated with malaria episodes at the household level. Indirect
costs, including productivity loss due to illness, were not accounted
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PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e107700
for. While the latter tend to dominate the economic cost of illness
[20–23], including these in cost-effectiveness analysis would result
in double-counting of intervention benefits [24–26].
Treatment costs are evaluated following a model of malaria case
management developed for endemic settings and is described
elsewhere [25]. Briefly, the entry point to the model is an acute
malaria episode from where treatment seeking is described in
terms of the formal and informal sector, and then by level of care
compliance with the recommended first-line antimalarial, and
further by type of treatment and adherence and drug quality of
that treatment. Defined in this manner, the methodology captures
patterns in health seeking behavior in a given setting that reflect
the underlying health systems infrastructure, quality of health care
delivery as well as individual preferences and beliefs about and
understanding of clinical outcomes associated with the illness. The
methodology to evaluate effectiveness of malaria service delivery
using data from national surveys and literature is detailed
elsewhere [27]. While the proportion of fevers in Kenya that
access medical care is estimated at 61.8% based on demographic
health and surveillance (DHS) data [28], effective coverage will be
much lower due to poor adherence to drug regimen, intake of
counterfeit antimalarials, and drug resistance [27].
On the provider side, cost per episode covers drugs, diagnosis,
medical personnel, facility charges, and other consumables. In
addition to the first-line antimalarial as per national malaria
guidelines, a portion of uncomplicated cases were assigned to
treatment with sulfadoxine pyrimethamine (SP) given evidence on
moderate uptake of AL, the first line artimisinin combination
therapy (ACT) in the study area [29,30]. Drug costs associated
with severe illness include intravenous and oral quinine, with
length of regimen varied by outcome. Kenya’s national policy of
treating severe illness with intra venous (IV) artesunate had not
been implemented at the time of the study and was therefore not
included in the costing model. For hospitalizations leading to
recovery, costs included an initial dose of IV quinine, followed by
three further days of IV quinine and four days oral quinine. For
severe cases that develop into neurological sequelae, costs included
an initial dose of IV quinine followed by 4.5 days of further IV
quinine treatment, and subsequent 5.5 days of oral quinine
therapy. Severe fatal events were assumed to occur within
48 hours of hospital admission and therefore involve only the
initial loading dose of IV quinine and two more days of IV quinine
treatment [31]. Drug costs were calculated according to age and
weight appropriate regimens [22]. Costs of diagnosis with RDT
were calculated proportionally to the fraction of fever cases tested.
Facility, personnel, linens, consumables and other outpatient
‘‘hotel’’ charges were obtained from the WHO-CHOICE project
[32]. Costs by facility type including health centers with beds,
health centers with no beds, and hospital outpatient and inpatient
departments were then matched with respective probability of
seeking care at a given level estimated from the 2009 Kenyan
DHS survey [28]. The DHS patterns in health seeking behavior
for febrile illness are likely representative of uncomplicated malaria
in countries with high levels of transmission, and somewhat biased
in countries with low EIR to the extent that mothers are able to
differentiate malaria from other febrile illnesses and care for their
children differently. For severe episodes treated in inpatient
settings, facility charges were scaled to account for length of
hospitalization: 4.5 days for severe episodes that recover, 10 days
for severe episodes that develop into neurological sequelae, and 2
days for terminal episodes [31]. Costs were inflated to 2012 using
Table 1. Experiment design of the combinations and coverage levels of interventions simulated for the study.
LLIN
use (%)
IRS coverage
(%)
IRS deployment
month
School-based
IST coverage (%)
IST frequency
(per school term)
Fevers receiving an
antimalarial (%)
Current strategy* 56 70 Alternating April/June 28
No intervention 28
Increase coverage 80 90 Alternating April/June 28
Add school-based IST 56 70 April 80 2 28
80 90 April 80 2 28
Change timing of IRS 56 70 April 28
56 70 May 28
56 70 June 28
Change timing and
increase coverage of IRS
56 90 April 28
56 90 May 28
56 90 June 28
IRS alone, change
coverage
70 Alternating April/June 28
90 Alternating April/June 28
LLINs alone 56 28
80 28
IST alone 40 1 28
40 2 28
80 1 28
80 2 28
*Represents the base case scenario as parameterized in Stuckey et al. 2012 [4].
doi:10.1371/journal.pone.0107700.t001
Cost Effectiveness of Malaria Control Interventions in Western Kenya
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e107700
the average annual CPI estimated over the 2008–2011 year period
[33] and can be found in Text S1.
Direct patient costs associated with a malaria episode include
travel expenses to and from healthcare facility and other
consumables (i.e. water, food, etc) and were based on the multi-
country literature review. Spending on consumables is generally
considered negligible; only a few studies recorded these data with
an average of $0.20 per visit [25,34,35]. For treatment outside of
the formal sector including pharmacy, shop, and other sources of
care based on self-diagnosis, it is assumed that patients do not
incur any additional costs to purchase the drug because these
providers are generally close to the patient’s home. Thus only drug
costs were added for treatments in informal sector.
Both average and marginal health system costs were calculated
for each outcome. The average cost includes all costs involved in
delivering a health intervention, including the use of spare capacity
or slack in the system, health care resources diverted from other
uses, and existing health sector resources shared with other health
programs. In the marginal analysis only costs of drugs, diagnosis,
and patient spending per visit were considered, as broader savings
to the health system including labour and capital costs would not
be immediately affected by changes in consumption of medical
services due to lower diseases burden achieved by control
interventions [31,36].
A sensitivity analysis was conducted for the costs of test and cost
per ACT dose by varying costs250%/+100%, and for proportion
of fevers that access medical care by varying access 2/+50%
(Table 2).
Costing interventions. A general approach for costing
malaria interventions using secondary data was applied as outlined
by Kolaczinski et al [37]. Current cost of commodities including
LLINs, insecticide, and drugs were sourced from the Global Fund
to Fight AIDS, Tuberculosis and Malaria Price and Quality
Reporting Tool [38]. Costs associated with delivery of interven-
tions and intervention mixes were estimated by reviewing Kenyan
field trials predominately from around the study area as identified
in a recent systematic review of costs of malaria interventions [39]
(Table 3). These non-tradable costs were expressed in Kenyan
Shillings, inflated to 2012 via Kenyan GDP deflator [33], and
converted into USD at reference year exchange rates [40].
Ingredient costs considered in the marginal analysis include
commodities, training and distribution. A sensitivity analysis was
conducted for the intervention costs by varying costs 250%/+
100% (Table 3).
Analysis
Epidemiological outcomes. The simulated effectiveness of
malaria control interventions and intervention combinations was
evaluated by calculating the mean and inter-quartile range (IQR)
of all model variants and seeds for each intervention combination
for the difference in disease burden over a five year period from
the start of intervention deployment compared to the mean of the
simulations of the base case scenario with no interventions other
than the existing case management system. Outcomes evaluated
include decrease in parasite prevalence, number of uncomplicated
episodes, hospitalizations and deaths averted in the general
population. In addition to indicators for severity of illness, the
overall population burden averted in terms of disability adjusted
life years (DALYs) is calculated by combining mortality and
morbidity measures as described by Murray and Lopez [25,41].
Table 2. Costing and sensitivity analysis of the Kenya public sector case management system.
Sensitivity analysis
Parameter Unit Value per unit Lower value Upper value
Cost per test ParacheckH rapid diagnostic test $0.62 [38] $0.31 $1.24
Cost per tablet, uncomplicated
treatment
CoartemH (Artemether-lumefantrine) $0.0898 [54] $0.045 $0.1769
Access to treatment Proportion of the most recent episode of fevers in
children under five within 2 week recall seeking
medical care
0.6183 [28] 0.309 0.927
All costs are in 2012 USD.
doi:10.1371/journal.pone.0107700.t002
Table 3. Costing and sensitivity analysis of malaria control interventions in Kenya.
Sensitivity analysis
Intervention Unit Distribution method
Economic cost
per unit
Marginal economic
cost per unit Lower value Upper value
Long lasting
insecticide-treated
bednets (LLIN)
Net delivered Mass campaign through
community organizations
[55]
$8.52 $8.37 $4.26 $17.04
Indoor residual
spraying (IRS)
Person protected Annual mass
campaign [55]
$0.73 $0.34 $0.34 $1.46
School-based
intermittent screen
and treat (IST)
Child screened School-based
distribution [56]
$6.32 $2.89 $3.16 $12.63
All costs are in 2012 USD.
doi:10.1371/journal.pone.0107700.t003
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Following standard methodology for cost effectiveness analysis
presented by Drummond and colleagues [24], years of life lost to
illness (YLLs) are calculated assuming age-specific life expectancies
based on the life-table from Butajira, Ethiopia, with an average life
expectancy of 46.6 years at birth [42].
Cost effectiveness calculation. Estimates of effectiveness of
control interventions and intervention mixes are combined with
the added costs of implementing these control measures.
Treatment cost savings, or the reduction in cost to the health
system due to the reduction in cases seen by the system, achieved
by implementing the control strategy, are used to offset
implementation costs and thus cost effectiveness ratios are
calculated based on net rather than total intervention costs.
The cost savings to the case management system and
households (CM) associated with implementing each intervention
combination (IC) instead of a scenario without interventions (NO)
are computed as DCcmNO2DCcmIC, where DCcmNO are the
direct costs (DC) of case management in the scenario without
interventions and DCcmIC are the direct costs of case management
in the case of each intervention combination. These cost savings
are subtracted from the direct cost of implementing each
intervention combination (DCint) to give a net intervention
combination cost (NC) computed as follows: NC=DCint2
(DCcmNO2DCcmIC). Cost effectiveness is evaluated in two ways.
The first is by calculating the average cost effectiveness ratio
(ACER), as the net cost (NC) of the intervention divided by the net
effects (NE) of the intervention. The second is by calculating the
incremental cost effectiveness ratio (ICER), which follows the same
methodology for calculating the ACER, except the net costs and
net effects of each intervention combination are calculated against
the currently implemented strategy.
Both marginal and average cost-effectiveness ratios over a five
year reference period are reported to illustrate the likely short-term
financial impact of the intervention, as well as the longer-term
impact associated with the intervention including structural
changes in health care delivery in response to lower disease
burden achieved by the program. Cost effectiveness ratios are
reported without discounting of future costs and benefits due to the
short implementation time frame of the study and the recom-
mendation from the revised GBD study [43]. Cost effectiveness
ratios are calculated for a range of policy relevant outcomes
including cost per case, hospitalization, death, and DALYs
averted.
Results
Epidemiological outcomes
Compared to an intervention scenario with no malaria control
outside of routine case management, and after five years of
implementation, the intervention combination with LLIN use by
80% of the population, 90% of households covered by IRS with
deployment starting in April, and IST of school children using AL
with 80% coverage twice per term result in the largest simulated
reduction in all-age parasite prevalence (99%, IQR 99.1–99.3%),
average averted cases of uncomplicated malaria per person (7.46,
IQR 7.44–7.48), hospitalizations averted (thousands)(3.96, IQR
3.95, 3.98), deaths averted (1,541, IQR 1,535, 1,551), and DALYs
averted (thousands) (77.6, IQR 77.3–78.2) (Table 4).
Simulation results indicate that increased coverage of vector
control has a larger impact than adding an IST intervention to the
current control strategy. However, adding the highest IST
coverage and frequency to the current strategy could reduce
parasite prevalence by an additional nine percentage points
(Figure 1). Despite high coverage levels of all interventions, the
scenario with the largest simulated epidemiological impact only
resulted in one fewer uncomplicated case per person over the
course of five years compared to the level observed in the study
area with the current strategy (Table 4). Changing the timing of
IRS deployment did not result in a reduction in simulated parasite
prevalence either at observed coverage levels or when coverage
was increased to 90% (Table 4).
Despite moderate levels of self-reported LLIN use, simulations
indicate LLINs, and not IRS, account for the majority of impact
on parasite prevalence. Removing LLINs and continuing only
with a higher level of IRS coverage resulted in a similar number of
averted uncomplicated cases compared to the IST interventions
(Table 4). With higher LLIN use, simulations indicate IRS adds
only a limited additional benefit above that provided by the nets
(Figure 1, Figure 2c).
Depending on coverage level and frequency, without vector
control interventions, simulations suggest IST could reduce annual
average parasite prevalence in the population by 9–22%
(Table 4). In the absence of vector control interventions, when
starting with the IST 40% coverage once per term scenario, and
compared to a scenario with no interventions, keeping the same
coverage and increasing doses to twice per term showed a similar
reduction in parasite prevalence as keeping the same frequency
and increasing IST coverage to 80% (Figure 2).
Costing
Total delivery costs and net health system costs for implement-
ing each intervention combination can be found in Table S1.
Program costs always exceeded savings in case management. The
top contributor to uncertainty in the highest coverage intervention
combination scenario was the cost per LLIN distributed, followed
by cost per child screened, ACT cost, cost per person protected by
IRS, and access to treatment (Figure 3). Because of a low
proportion of fevers tested for malaria with an RDT (12%), test
cost did not contribute greatly to overall uncertainty.
Intervention combination cost effectiveness
Five intervention combinations simulated more averted DALYs
than the currently-implemented intervention combination (Ta-
ble 4, Figure 4). All of these intervention combinations involve
increasing coverage of LLINs, of IRS, or both, with the exception
of one which adds IST to the current strategy (Table 4,
Figure 4). However, none of these options were simulated to be
more cost effective than the current strategy (Table 5). All
interventions can be considered very cost effective health
interventions. The currently implemented intervention combina-
tion has a simulated ACER of 4.29 USD per DALY averted, but
even the intervention combination with the highest cost per
additional DALY averted, IST at 80% coverage twice per term,
has a simulated ACER of only 55.70 USD (Table 5).
Discussion
Cost effectiveness analyses based on health outcomes simulated
by transmission models can compare many more intervention
effects than can static models or field trials. In these simulations,
interventions simulate a decrease in vector population and a
corresponding decrease in transmission that allows for mass
community effects of interventions. In particular, such models can
explore the effects of intervention scenarios by transmission level
and coverage level whereas in single field studies all the effects of
different interventions cannot be captured.
Increased coverage and use of vector control interventions has a
larger simulated impact on all malaria indicators than adding IST
Cost Effectiveness of Malaria Control Interventions in Western Kenya
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to the currently implemented control strategy. There could be
additional impact of IST programs not captured in this analysis,
including improved school performance and decreased anemia
[44]. While results from a cluster-randomized trial of once per
term IST in school children in the south coast of Kenya at similar
coverage levels did not show an impact on parasitaemia [45],
effectiveness of the program will depend on baseline parasitaemia
and results may be different in Rachuonyo South District. Results
suggests that, at least at transmission levels comparable to those in
the study area, it would not be warranted to take focus away from
vector control in favor of a school-based IST program even at a
deployment frequency of twice per term, assuming such a level
exists where this would be advisable. The simulated screen and
treat campaign in this study was limited to school children, and
incorporating a focal- or mass screen and treat program in the
community may have very different results. However, should
Rachuonyo South District decide to implement an IST program,
simulations indicate adding this intervention to the existing
malaria control program could still be a cost-effective intervention
with a mean simulated ICER of only 66 USD above the currently
implemented strategy (Table 5).
Despite moderate observed use in the population, simulations
show LLINs and not IRS account for the majority of impact on
disease burden. Changing the timing of IRS implementation did
not have a large impact on parasite prevalence. This could be due
to the simulation experiment design, which models implementa-
tion of IRS programs rolled out over a 60 day period culminating
in the target proportion of individuals protected. Because the start
date of implementation was varied by 30 days at a time,
implementation could overlap enough to prevent observing a
substantial difference between scenarios. Rather than changing the
timing or coverage of IRS, the study area may benefit from adding
new vector control interventions, particularly those targeting
exophagic and exophilic vectors.
The simulation results for the effect of the currently-imple-
mented strategy on parasite prevalence in the study area have
been previously validated and found to be in the range of the
effects observed in the field [4]. The large simulated reduction in
parasite prevalence compared to a case-management only strategy
in many of the simulated intervention combinations described in
Figure 2 can be attributed to high coverage of interventions over
an extended period of time, conditions which may or not be
operationally sustainable.
Limitations
While interventions were chosen to correspond to those in the
hotspot-targeted intervention study, simulated implementation
was assumed for the whole population rather than target hot spots
because OpenMalaria does not incorporate an explicit spatial
element. Therefore results cannot be matched against intervention
trial results for validation purposes. However, findings from this
experiment can help put the trial results in the broader context of
what could be expected from community-wide implementation of
combinations of interventions.
While simulations of the scenarios describing the effects of the
intervention combinations in reducing malaria burden account for
uncertainty by employing an ensemble of 14 model variants and
multiple random seeds, uncertainty in the costing model is limited
to a one-way sensitivity analysis. A probabilistic sensitivity analysis
exposing the model to changes in assumptions of inputs to the case
management and intervention unit costs is being conducted for
Figure 1. Simulated reduction in all-age annual average parasite prevalence by intervention combination compared to a scenario
with no intervention. White lines represent the simulated median value, blue boxes represent the inter-quartile range, and capped bars represent
the upper and lower adjacent values for simulated results for each intervention combination using an ensemble of 14 model variants and five
random seeds. Choice of intervention combinations is based on the criteria of simulated reduction in parasite prevalence greater than the strategy
currently implemented in the study area.
doi:10.1371/journal.pone.0107700.g001
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publication elsewhere, and will assist in clarifying the uncertainty
inherent in these predictions.
Despite vector behavior in the study area favoring outdoor
biting, IRS had a lower health impact than expected when
simulated as a stand-alone intervention when compared to LLINs.
The IRS model parameterization has deterrency and killing effects
of half that of LLINs, due to simulated action only on post-
prandial indoor resting mosquitoes, in contrast to the both pre-
and post- prandial killing effect of LLINs. A model update will
allow the effect of IRS to be simulated on both states of the
mosquito feeding cycle, and the parameters for effectiveness of
IRS should be updated based on experimental hut data. It is also
worth noting the lower cost per sachet of insecticide assumed in
the costing model compared to the average unit costs reported in
the recently released UNITAID report on malaria vector control
commodities [46], due to the economies of scale achieved through
a multi-country procurement by the IRS implementing partner
[47].
Implications of results for health systems
Results of this experiment have the potential to assist malaria
control program managers in the study area in deciding on adding
new or changing the implementation of current interventions. All
the simulated intervention combinations can be considered cost
effective in the context of levels of health expenditure in Kenya.
Malaria is the number six contributor to the burden of disease in
Kenya, both overall and in children under five [48]. The low cost
per DALY averted by the malaria control interventions with a
higher simulated number of DALYs averted than the current
strategy represents a small portion of the total health expenditure
per capita of 42 USD [13] and could be a cost effective option for
reaching the country’s development strategies. In comparison with
estimates from a recent systematic review on costs and cost
effectiveness of malaria control interventions [39], these results are
on the low end of the range of previous estimates. Similarly,
compared to WHO-CHOICE estimates for the AFR-E region,
while the simulated DALYs averted per year for the currently-
implemented strategy are comparable to WHO estimates for 50%
coverage of vector control interventions (14,296 simulated, 14,711
observed), the simulated cost per DALY averted are substantially
lower than the regional averages when converted to 2012 USD
(4.29 2012 USD simulated, 50 2005 International Dollars (I$)
observed) [49]. This puts malaria prevention interventions in the
study area in the range of regional estimates for tuberculosis (6–15
2005 I$ per DALY averted) [50] and HIV prevention commu-
nication (3–4 2005 I$ per DALY averted) [51].
Findings from this study indicate there are several combinations
of interventions that could result in a greater health impact per
dollar spent than the currently implemented strategy in the study
area. However, increasing LLIN use and IRS coverage and
initiating a school-based IST program will require investment in
several elements not included in this analysis. Firstly, the unit costs
of scaling up or introducing some programs will vary by
implementation strategy more than others. For example, the
majority of the economic cost of the LLIN program implemented
by training existing community organizations on distribution is
represented by the marginal cost of procuring nets (Table 3).
Therefore a change in strategy may not result in a large change in
cost per net delivered due to increased or decreased non-
commodity costs. The reverse is true for a school-based IST
program where marginal costs are under half the cost per child
screened (Table 3), and could therefore be far more sensitive to
changes in program design.
Figure 2. Relationship between cost and simulated health
impact. Simulated cumulative DALYs averted after five years compared
to the no intervention scenario by net program costs for different
implementation strategies of a) vector control interventions, b)
intermittent screen and treat in school children, and c) combinations
of interventions. Symbols represent the mean simulation results across
14 model variants and five random seeds. Horizontal capped bars
represent range of simulated DALYs averted. Vertical capped bars
represent range of simulated net program costs. Negative DALYs
averted indicate simulated interventions that have a worse health
outcome than the no intervention scenario. Negative net program costs
indicate simulated interventions where the savings to the health system
are greater than the delivery costs.
doi:10.1371/journal.pone.0107700.g002
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Figure 3. Sensitivity analysis. Tornado diagram of the change in the ACER of an intervention with 80% LLIN use, 90% IRS coverage, and 80% IST
coverage twice per term in relation to variation in component costs.
doi:10.1371/journal.pone.0107700.g003
Figure 4. Cost effectiveness planes. Simulated cumulative DALYs averted in a population of 100,000 individuals after five years compared to the
no intervention scenario by net program costs for the intervention combinations with a better simulated health outcome than the currently
implemented malaria control strategy, ranked in descending order of ACER. Black dots represent the mean simulation results across 14 model
variants and five seeds. Circles represent the of simulated DALYs averted by net program costs with different assumptions of input costs of the case
management system and malaria control interventions in the study area represented in Table 2 and Table 3. Dark blue circles are within the inter-
quartile range of simulated DALYs averted and light blue circles are outside the range. Negative DALYs averted indicate simulated interventions that
have a worse health outcome than the no intervention scenario. Negative net program costs indicate simulated interventions where the savings to
the health system are greater than the delivery costs. Diagonal lines correspond to the ratios of mean (4.29 USD per DALY averted) ACER of the
currently implemented intervention combination in the study area (LLIN use 56%, IRS coverage 70%).
doi:10.1371/journal.pone.0107700.g004
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Secondly, additional costs will be incurred by determining the
appropriate strategy for achieving programmatic goals. Several
scenarios in this experiment assume LLIN use of 80%, which is an
ambitious target that will depend not only on universal coverage
but a large behavior change communications component.
Understanding of the behavioral determinants for why nets
existing in households currently remain unused will be critical to
achieving this goal. In addition to increased personnel and
commodities, increasing coverage of IRS will require continued
monitoring of insecticide resistance in the vector population, as
well as understanding why households remain unsprayed, whether
it is due to rejection by household members or the inability to
logistically access hard to reach households. Implementing a
school-based IST program as intensive as twice per school term
over an extended period of time could result in a change in
adherence rates as well as an increased risk of selecting for drug
resistance, elements which may impact the effectiveness of the
intervention if community acceptability is not assessed.
Thirdly, the study does not allow for any economies or
diseconomies of scale for the costs of commodities and program
delivery, assuming costs will grow linearly with scale up. In
practice this will likely not be the case; increasing intervention
coverage from 70% to 80% may be more expensive than scaling
up from 50% to 60%.
Assessing the epidemiologic impact and cost effectiveness of
different intervention combinations is a necessary element in
considering a change of malaria control policy, but it is by no
means the only criteria with which to base a recommendation for
policy change. Changes in implementation, whether this includes
new strategies to increase coverage and use of existing interven-
tions or the addition of a new intervention, will have implications
on acceptability by the individuals and communities receiving the
interventions, the personnel involved in service delivery, the
natural environment into which additional insecticides could be
introduced, and the systems of surveillance and monitoring for
indicators of malaria and other febrile illnesses, to name a few.
Conducting a health impact assessment, drawing on existing
frameworks [52,53], may strengthen the success of any change in
strategy.
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Table 5. Cost effectiveness of different intervention combinations for a population of 100,000 over five years of implementation
(2012 US$).
Average ACER Marginal ACER Average ICER Marginal ICER
Mean IQR Mean IQR Mean Mean
Current strategy
Current strategy: LLIN 55%, IRS 70% 4.29 (4.22, 4.33) 6.30 (6.28, 6.31)
Change timing and increase
coverage of IRS
LLIN 55%, IRS 90% May start 5.27 (5.21, 5.31) 6.75 (6.74, 6.75) 235.46 111.58
LLIN 55%, IRS 90% June start 5.11 (5.06, 5.13) 6.62 (6.61, 6.62) 50.24 24.27
Add IST
Add IST to the current strategy 6.13 (6.09, 6.14) 7.02 (7.01, 7.03) 66.03 30.55
Increase coverage
LLIN 80%, IRS 90% 7.39 (7.38, 7.40) 8.92 (8.92, 8.92) 53.75 48.06
Add IST, increase coverage
LLIN 80%, IRS 90%, IST 80% twice per
term
9.06 (9.04, 9.05) 9.59 (9.58, 9.60) 65.05 48.27
The mean and inter-quartile range of the average cost effectiveness ratios (ACER) compared to a scenario with no interventions outside the existing case management
system, and incremental cost effectiveness ratios (ICER) compared to the currently implemented strategy for different intervention combinations with more simulated
DALYs averted than the currently implemented strategy. ACERs and ICERs are calculated using costs reported in Table S1 and effectiveness reported in Table 1.
Interventions are displayed in ascending order of simulated DALYs averted (Table 1). IQR represents mean costs values applied to the inter-quartile range of simulated
health effects.
doi:10.1371/journal.pone.0107700.t005
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